Q2 revenue rises 10%, profit rises 14%; Anoop Moopen resigns
ASTERDM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.7 pts more than Nifty Smallcap 250 and 0.5 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board approved unaudited Q2 and half-year results. Consolidated operating revenue rose 10.2% year on year to INR 1,197.21 crore, while profit attributable to owners rose 13.6% to INR 110.00 crore; EPS was INR 2.13. Half-year cash generated from operations rose 58.3% to INR 319.20 crore. The auditor's limited review found no material issue. Exceptional merger and acquisition costs were INR 4.75 crore. Director Anoop Moopen also resigned.
Positive earnings and cash flow may support the stock, though growth was moderate. Anoop Moopen's exit creates uncertainty over board continuity.